By Kathleen Gallagher, Milwaukee Journal Sentinel
Arrowhead Research Corp., a California company that is aiming to develop a cure for hepatitis B, is planning to expand its research facilities in Madison with construction of a 45,000 square-foot laboratory facility.
“This expansion shows confidence in their method of treatment, R&D investment, and in Wisconsin as an ecosystem of research,” said Brian Moeller, operations manager at BioForward, the trade association for the state’s biotech industry.
The building, which Arrowhead hopes to complete by August, will be designed by Eppstein Uhen Architects, the firm said in a news release. It will be in University Research Park on Madison’s west side. Read more …